Research conducted by University of North Carolina School of Medicine has discovered two subtypes of the disease - with different gene expressions and clinical features - that may reveal why such variations in disease progression surface between patients.
Low-dose, intravenous administration of the anesthetic drug ketamine helped to bring down suicidal thoughts on patients that did not show any response to antidepressants.
The American Academy of Neurology recommends using Botox to treat diverse neurological ailments, including chronic and episodic migraines.
